Neurology

Stroke survivors with hypertension may have a new ally in reducing their risk of post-stroke epilepsy (PSE): angiotensin receptor blockers (ARBs).

New research offers insights into medical factors linked to the absence of Alzheimer’s disease neuropathologic changes (ADNC) in individuals aged 90 and older.

The real-world impact of symptoms in Alzheimer’s disease (AD), mild cognitive impairment (MCI), and dementia from the perspectives of patients and their caregivers has been investigated in a recent study.

A direct link between visceral fat and the presence of brain abnormalities associated with Alzheimer’s disease, up to 20 years before symptoms appear, has been identified in a new study.

A functional brain biomarker that could revolutionize psychosis detection has been identified in a new study.

Accurately diagnosing Alzheimer’s disease (AD) may soon become more efficient, thanks to a novel biomarker assessment strategy leveraging cerebrospinal fluid (CSF) and PET imaging data, according to a 10-year study conducted at university memory clinics in Europe.

Patients with multiple sclerosis (MS) may experience a slightly increased risk of developing cancer compared to the general population, according to a new nationwide French study spanning 10 years.

Clonazepam has been recalled due to potential product carton strength mislabeling. Endo Pharmaceuticals (Malvern, Pennsylvania) has issued a voluntary, nationwide recall of a specific lot of Clonazepam Orally Disintegrating Tablets (USP, C-IV).